GENETIC TECHNOLOGIES LIMITED Deciphering the Lingo - Biotechs Forum; (ASX: GTG) - Dr Mervyn Jacobson, CEO; Boardroomradio is pleased to announce that GENETIC TECHNOLOGIES LIMITED (ASX: GTG) has published an audio file. The following presentation "GTG - Market Briefing" is now available as an instant audio download to your computer. You may also transfer this information to your listening device as an IPod podcast.
The BRR service is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Broadcaster: GENETIC TECHNOLOGIES LIMITED (ASX: GTG)
Broadcast Title: GTG - Market Briefing
Broadcast Type: Audio stream
View the Audio stream for GENETIC TECHNOLOGIES LIMITED (ASX: GTG) by clicking on the following links.
Display in Windows Media Player
http://www.boardroomradio.com/event/GTG/1275/10148/wmp/221.242.254.150/wsl.wmp?
or:
Display in MP3 Player or Transfer to Portable Podcast Device
http://www.boardroomradio.com/event/GTG/1275/10148/mp3/221.242.254.150/wsl.mp3?
Computers set up for access to the Internet, including at least a 28.8k modem and sufficient memory and hard disk space to run Windows Media Player or Real Player, should be able to run BRR media files.
About Boardroom Media
Boardroom.Media is a new breed of media company that's equal parts publisher, content producer, and streaming media technology business. With a strong footing in capital markets, professional services and asset management, the company has been a leading provider of multimedia communication solutions for corporate Australia for more than a decade.
About Genetic Technologies Limited
Genetic Technologies was an early pioneer in recognizing important new applications for "non-coding" DNA (DeoxyriboNucleic Acid). The Company has since been granted patents in 24 countries around the world, securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species. Its three-pronged business strategy includes: 1) the global commercialization of its patents through an active licensing program; 2) the expansion of its dominant commercial genetic testing business in Australia; and, 3) the commercialization of its various research and development projects aimed at generating further intellectual property of global commercial significance.
Related Companies
Related Industry Topics: